These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 15064751)
1. Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells. Li HM; Zhuang ZH; Wang Q; Pang JC; Wang XH; Wong HL; Feng HC; Jin DY; Ling MT; Wong YC; Eliopoulos AG; Young LS; Huang DP; Tsao SW Oncogene; 2004 May; 23(25):4488-94. PubMed ID: 15064751 [TBL] [Abstract][Full Text] [Related]
2. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth. Kim KR; Yoshizaki T; Miyamori H; Hasegawa K; Horikawa T; Furukawa M; Harada S; Seiki M; Sato H Oncogene; 2000 Mar; 19(14):1764-71. PubMed ID: 10777210 [TBL] [Abstract][Full Text] [Related]
3. Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells. Yang J; Deng X; Deng L; Gu H; Fan W; Cao Y J Exp Clin Cancer Res; 2004 Sep; 23(3):495-506. PubMed ID: 15595642 [TBL] [Abstract][Full Text] [Related]
4. Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells. Man C; Rosa J; Lee LT; Lee VH; Chow BK; Lo KW; Doxsey S; Wu ZG; Kwong YL; Jin DY; Cheung AL; Tsao SW Oncogene; 2007 May; 26(21):3069-80. PubMed ID: 17099724 [TBL] [Abstract][Full Text] [Related]
5. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Zheng H; Li LL; Hu DS; Deng XY; Cao Y Cell Mol Immunol; 2007 Jun; 4(3):185-96. PubMed ID: 17601372 [TBL] [Abstract][Full Text] [Related]
6. Expression of Epstein-Barr virus-encoded LMP1 and hTERT extends the life span and immortalizes primary cultures of nasopharyngeal epithelial cells. Yip YL; Tsang CM; Deng W; Cheung PY; Jin Y; Cheung AL; Lung ML; Tsao SW J Med Virol; 2010 Oct; 82(10):1711-23. PubMed ID: 20827769 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line. Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743 [TBL] [Abstract][Full Text] [Related]
8. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB. Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943 [TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. Mainou BA; Everly DN; Raab-Traub N Oncogene; 2005 Oct; 24(46):6917-24. PubMed ID: 16007144 [TBL] [Abstract][Full Text] [Related]
10. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Eliopoulos AG; Young LS Oncogene; 1998 Apr; 16(13):1731-42. PubMed ID: 9582021 [TBL] [Abstract][Full Text] [Related]
11. Lack of cytotoxic property in a variant of Epstein-Barr virus latent membrane protein-1 isolated from nasopharyngeal carcinoma. Nitta T; Chiba A; Yamamoto N; Yamaoka S Cell Signal; 2004 Sep; 16(9):1071-81. PubMed ID: 15212767 [TBL] [Abstract][Full Text] [Related]
12. The transmembrane domains of the EBV-encoded latent membrane protein 1 (LMP1) variant CAO regulate enhanced signalling activity. Blake SM; Eliopoulos AG; Dawson CW; Young LS Virology; 2001 Apr; 282(2):278-87. PubMed ID: 11289810 [TBL] [Abstract][Full Text] [Related]
13. The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells. Miller WE; Cheshire JL; Baldwin AS; Raab-Traub N Oncogene; 1998 Apr; 16(14):1869-77. PubMed ID: 9583684 [TBL] [Abstract][Full Text] [Related]
14. The latent membrane protein 1 of Epstein-Barr virus and loss of the INK4a locus: paradoxes resolve to cooperation in carcinogenesis in vivo. Macdiarmid J; Stevenson D; Campbell DH; Wilson JB Carcinogenesis; 2003 Jul; 24(7):1209-18. PubMed ID: 12807717 [TBL] [Abstract][Full Text] [Related]
15. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion. Ho CH; Chen CL; Li WY; Chen CJ Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191 [TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma. Wang C; Ai M; Ren W; Xiao H; Li X; Tang F; Gu H; Yi W; Weng X; Deng X; Cao Y Chin Med J (Engl); 2003 Jul; 116(7):1022-8. PubMed ID: 12890376 [TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells. Liu MT; Chen YR; Chen SC; Hu CY; Lin CS; Chang YT; Wang WB; Chen JY Oncogene; 2004 Apr; 23(14):2531-9. PubMed ID: 14716302 [TBL] [Abstract][Full Text] [Related]
18. Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells. Lo AK; Huang DP; Lo KW; Chui YL; Li HM; Pang JC; Tsao SW Int J Cancer; 2004 May; 109(6):919-25. PubMed ID: 15027126 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner. Tao YG; Tan YN; Liu YP; Song X; Zeng L; Gu HH; Tang M; Li W; Yi W; Cao Y Cell Signal; 2004 Jul; 16(7):781-90. PubMed ID: 15115657 [TBL] [Abstract][Full Text] [Related]
20. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Huen DS; Henderson SA; Croom-Carter D; Rowe M Oncogene; 1995 Feb; 10(3):549-60. PubMed ID: 7845680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]